A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer

Editorial

M R Hudson. J Urol. 1996 Sep.

. 1996 Sep;156(3):972-4.

doi: 10.1016/s0022-5347(01)65675-1.

No abstract available

Comment on

Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen SC, Groshen S, Simoneau A, Skinner EC, Lieskovsky G, Boyd SD, Cote RJ, Skinner DG. Esrig D, et al. J Urol. 1996 Sep;156(3):1071-6. J Urol. 1996. PMID: 8709310
A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.
Krege S, Giani G, Meyer R, Otto T, Rübben H. Krege S, et al. J Urol. 1996 Sep;156(3):962-6. doi: 10.1016/s0022-5347(01)65673-8. J Urol. 1996. PMID: 8709374 Clinical Trial.
Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K. Okamura T, et al. J Urol. 1996 Sep;156(3):967-71. J Urol. 1996. PMID: 8709375 Clinical Trial.